Plasma Cell Leukemia
📧 Sign up to get email alerts when something new happens for Plasma Cell Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: An Investigator-Initiated, Phase II, Multicenter, Open-Label, Single-Arm, Prospective Clinical Trial to Evaluate the Efficacy and Safety of Alternating Bortezomib-Based Regimens in Combination With DaratUMumab Followed by Maintenance With Daratumumab in the Frontline Setting of Primary Plasma CEll L [Phase 2]
This entry describes a Phase II investigator-initiated, multicenter trial evaluating alternating bortezomib-based regimens with daratumumab,…